Axiom Therapeutics

Axiom Therapeutics is a UK biotech company developing a computational platform for covalent drug discovery.

Its platform combines machine learning with molecular physics to predict covalent binding interactions and design small molecule drug candidates against targets previously considered undruggable.

The company maintains a virtual library of over 100 million potential covalent compounds and is advancing a proprietary pipeline in oncology and neurodegeneration alongside partnerships with pharmaceutical companies.